← FDA Drug Approvals (Drugs@FDA)

RANOLAZINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: I3 PHARMS · Approved 2022-04-27

Drug application

FDA Application #

ANDA213517

Application type

Abbreviated New Drug Application (Generic)

Brand name

RANOLAZINE

Generic name

RANOLAZINE

Active ingredients

RANOLAZINE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

I3 PHARMS

Manufacturer

A2A Integrated Pharmaceuticals

First approval

2022-04-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown